Kazazian Asset Management, LLC Cytokinetics Inc Transaction History
Kazazian Asset Management, LLC
- $123 Billion
- Q1 2025
A detailed history of Kazazian Asset Management, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Kazazian Asset Management, LLC holds 9,796 shares of CYTK stock, worth $320,623. This represents 0.32% of its overall portfolio holdings.
Number of Shares
9,796
Previous 5,236
87.09%
Holding current value
$320,623
Previous $246 Million
59.85%
% of portfolio
0.32%
Previous 0.19%
Shares
2 transactions
Others Institutions Holding CYTK
# of Institutions
408Shares Held
127MCall Options Held
3.66MPut Options Held
900K-
Black Rock Inc. New York, NY14.7MShares$480 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$388 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.96MShares$326 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA7.99MShares$261 Million0.06% of portfolio
-
State Street Corp Boston, MA6.09MShares$199 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.08B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...